NOVARTINDBSENovartis India LtdMinimalNeutral
Announced Sat, 6 Jun · 19:28 IST

Intimation of Newspaper Advertisement of Novartis India Limited ("The Company/ The Target Company") regarding the reasoned recommendations of the Committee of Independent Directors ("IDC").

NOVARTIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.9%1-day move
₹1398.00
prior close
₹1384.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.5+1.1+0.5-5.9-4.8-4.4-6.5-7.6-2.3+2.3+3.9
Up moveDown movePending
AI summary

Novartis India has informed BSE about the publication of newspaper advertisements containing the reasoned recommendations of its Committee of Independent Directors (IDC) in connection with an ongoing open offer for the company. The IDC met on June 04, 2026 and its recommendations were published on June 06, 2026 in Financial Express (English, all editions), Jansatta (Hindi, all editions) and Navshakti (Marathi, Mumbai edition). The open offer is being made by WaveRise Investments, ChrysCapital Fund X (first scheme of ChrysCapital Trust I) and Two Infinity Partners, together with PACs ChrysCapital X, LLC and OceanEdge Investments Limited. The filing is made under SEBI Takeover Regulations and SEBI Listing Regulations to inform the public shareholders of the company.

Likely market impact

Public shareholders now have access to the IDC's formal view on whether the open offer price is fair and whether they should tender their shares. The multilingual newspaper publication is intended to ensure maximum reach among retail investors, helping them make an informed decision before the offer's tendering window closes.